13-31276666-C-CACAT
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_194318.4(B3GLCT):c.781-34_781-31dupCATA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.172 in 1,383,016 control chromosomes in the GnomAD database, including 23,083 homozygotes. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..
Frequency
Genomes: 𝑓 0.14 ( 1908 hom., cov: 29)
Exomes 𝑓: 0.18 ( 21175 hom. )
Consequence
B3GLCT
NM_194318.4 intron
NM_194318.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.906
Genes affected
B3GLCT (HGNC:20207): (beta 3-glucosyltransferase) The protein encoded by this gene is a beta-1,3-glucosyltransferase that transfers glucose to O-linked fucosylglycans on thrombospondin type-1 repeats (TSRs) of several proteins. The encoded protein is a type II membrane protein. Defects in this gene are a cause of Peters-plus syndrome (PPS).[provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 13-31276666-C-CACAT is Benign according to our data. Variant chr13-31276666-C-CACAT is described in ClinVar as [Benign]. Clinvar id is 1192419.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.187 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.139 AC: 21168AN: 151936Hom.: 1908 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
21168
AN:
151936
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.156 AC: 37837AN: 243054 AF XY: 0.157 show subpopulations
GnomAD2 exomes
AF:
AC:
37837
AN:
243054
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.176 AC: 216920AN: 1230962Hom.: 21175 Cov.: 18 AF XY: 0.175 AC XY: 109026AN XY: 624640 show subpopulations
GnomAD4 exome
AF:
AC:
216920
AN:
1230962
Hom.:
Cov.:
18
AF XY:
AC XY:
109026
AN XY:
624640
Gnomad4 AFR exome
AF:
AC:
901
AN:
29150
Gnomad4 AMR exome
AF:
AC:
7194
AN:
44326
Gnomad4 ASJ exome
AF:
AC:
3327
AN:
24680
Gnomad4 EAS exome
AF:
AC:
37
AN:
38690
Gnomad4 SAS exome
AF:
AC:
10444
AN:
81590
Gnomad4 FIN exome
AF:
AC:
13222
AN:
50090
Gnomad4 NFE exome
AF:
AC:
172168
AN:
904360
Gnomad4 Remaining exome
AF:
AC:
8708
AN:
52760
Heterozygous variant carriers
0
9004
18008
27011
36015
45019
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
5318
10636
15954
21272
26590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.139 AC: 21163AN: 152054Hom.: 1908 Cov.: 29 AF XY: 0.142 AC XY: 10548AN XY: 74306 show subpopulations
GnomAD4 genome
AF:
AC:
21163
AN:
152054
Hom.:
Cov.:
29
AF XY:
AC XY:
10548
AN XY:
74306
Gnomad4 AFR
AF:
AC:
0.0341314
AN:
0.0341314
Gnomad4 AMR
AF:
AC:
0.165684
AN:
0.165684
Gnomad4 ASJ
AF:
AC:
0.140841
AN:
0.140841
Gnomad4 EAS
AF:
AC:
0.00212028
AN:
0.00212028
Gnomad4 SAS
AF:
AC:
0.117928
AN:
0.117928
Gnomad4 FIN
AF:
AC:
0.267579
AN:
0.267579
Gnomad4 NFE
AF:
AC:
0.190068
AN:
0.190068
Gnomad4 OTH
AF:
AC:
0.152174
AN:
0.152174
Heterozygous variant carriers
0
876
1752
2628
3504
4380
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
236
472
708
944
1180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
176
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Peters plus syndrome Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Jul 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BranchPoint Hunter
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at